0

Cinnamyl-3,4-dihydroxy-α-cyanocinnamate

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP132465113
CAS132465-11-3
Structure
MDL NumberMFCD00210839
Molecular Weight321.33
InChI KeyXGHYFEJMJXGPGN-UYHGDYIZSA-N
Description≥98% (HPLC)
SolubilityDMSO: ≥15 mg/mL
Assay≥98% (HPLC)
Colorlight yellow to yellow
Formpowder
Size5MG, 25MG
Storage Conditionsroom temp
1

A 4-oxo-2(E)-nonenal-derived Glutathione Adduct From 15-lipoxygenase-1-mediated Oxidation of Cytosolic and Esterified Arachidonic Acid

Peijuan Zhu, Wenying Jian, Ian A Blair

Free Radic Biol Med. 2009 Oct 1;47(7):953-61.

PMID: 19576981

1

Cinnamyl-3,4-dihydroxy-alpha-cyanocinnamate and Nordihydroguaiaretic Acid Inhibit Human Kv1.5 Currents Independently of Lipoxygenase

Ying-Zi Gong, Wei-Guang Ding, Jie Wu, Keiko Tsuji, Minoru Horie, Hiroshi Matsuura

Eur J Pharmacol. 2008 Dec 14;600(1-3):18-25.

PMID: 18930721

1

Cinnamyl-3,4-dihydroxy-α-cyanocinnamate Is a Potent Inhibitor of 5-lipoxygenase

Carlo Pergola, Bianca Jazzar, Antonietta Rossi, Ulrike Buehring, Susann Luderer, Friederike Dehm, Hinnak Northoff, Lidia Sautebin, Oliver Werz

J Pharmacol Exp Ther. 2011 Jul;338(1):205-13.

PMID: 21447614

1

Pharmacological Roles of the Large-Conductance Calcium-Activated Potassium Channel

Sheng-Nan Wu, Adonis Z Wu, Ming-Wei Lin

Curr Top Med Chem. 2006;6(10):1025-30.

PMID: 16787277

1

Platelet Activation Triggered by Chlamydia Pneumoniae Is Antagonized by 12-lipoxygenase Inhibitors but Not Cyclooxygenase Inhibitors

Hanna Kälvegren, Johanna Andersson, Magnus Grenegård, Torbjörn Bengtsson

Eur J Pharmacol. 2007 Jul 2;566(1-3):20-7.

PMID: 17459368

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode